研究领域
• 暂无内容

论文成果 More>>
• 张彬. Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy.  Journal of biological chemistry,  300,  2024. 
• 王清池. Distinct mechanisms underlying the therapeutic effects of low-molecular-weight heparin and chondroitin sulfate on Parkinson's disease.  International Journal of Biological Macromolecules,  262,  2024. 
• . Inhibition of catechol-O-methyltransferase (COMT) by heparin oligosaccharides with specific structures.  Carbohydrate Polymers,  332,  2024. 
• 安子哲. Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD.  International Journal of Biological Macromolecules,  259,  2024. 
• 迟连利. The alterations and roles of glycosaminoglycans in human diseases.  POLYMERS,  5014, 2022. 

专利
• 暂无内容

著作成果
• 暂无内容

科研项目 More>>
• 肠道噬菌体在腹主动脉瘤中的病因学作用和应用转化价值的多模态研究,2024-01-01,2026-12-31
• （包干项目）低分子量硫酸软骨素E对帕金森病的改善作用及分子机制研究,2022-11-01,2025-12-30

科研团队
• 暂无内容